节点文献

机器人与胸腔镜肺段切除术治疗早期非小细胞肺癌疗效的对比研究

Comparison analysis of robot-assisted and video-assisted thoracic surgery segmentectomy for early stage non-small cell lung cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 贾卓奇王绩钊王哲张勇吴齐飞张广健付军科

【Author】 JIA Zhuoqi;WANG Jizhao;WANG Zhe;ZHANG Yong;WU Qifei;ZHANG Guangjian;FU Junke;Department of Thoracic Surgery,First Affiliated Hospital of Xi’an Jiaotong University;

【通讯作者】 付军科;

【机构】 西安交通大学第一附属医院胸外科

【摘要】 目的:对比分析达芬奇机器人与胸腔镜肺段切除术治疗早期非小细胞肺癌(non-small cell lung cancer, NSCLC)的临床疗效。方法:回顾性分析2016年06月至2020年12月,于我院胸外科行微创肺段切除术的早期非小细胞肺癌患者,共纳入134例,分为机器人组(robot-assisted thoracic surgery, RATS)47例,胸腔镜组(video-assisted thoracic surgery, VATS)87组,对比分析两组临床特征及手术指标、术后主要并发症情况及费用。结果:手术时间、术中出血、平均住院日、术后引流时间等,RATS组优于VATS组,但两组差异无统计学意义(P>0.05)。术后并发症如肺炎、胸腔积液、心律失常、肺不张发生率,两组间差异无统计学意义(P>0.05)。超过5天漏气率RATS组为6.3%,低于VATS组的10.3%,差异有统计学意义(P<0.05)。两组术后NRS疼痛评分差异无统计学意义(P>0.05)。RATS组住院费用明显高于胸腔镜组,差异有统计学意义(P<0.05)。两组1年生存率和2年生存率差异均无统计学意义(P>0.05)。结论:机器人肺段切除术治疗早期非小细胞肺癌安全可行,与胸腔镜相比,术后长期漏气发生较少,值得推广应用。

【Abstract】 Objective:To compare the clinical efficacy of Da-Vinci robot-assisted and video-assisted thoracic surgery segmentectomy for early stage non-small cell lung cancer(NSCLC).Methods:From June 2016 to December 2020,total of 134 early stage non-small cell lung cancer patients who accepted minimally invasive segmentectomy in department of thoracic surgery of our hospital, were analyzed retrospectively, including robot-assisted thoracic surgery(RATS) group(n=47) and video-assisted thoracic surgery(VATS) group(n=87).The clinical efficacy, post-operative complications and hospitalization cost of two groups were compared and analysed.Results:The operation time, intraoperative bleeding, hospital stayand drain time in RATS group was better than VATS group, but no statistically significant difference(P>0.05).The rate of post-operative complications as pneumonia, pleural effusion, arrhythmia and atelectasis of two group were not statistically difference(P>0.05).The rate of air leak>5 d in RATS group (6.3%) was lower than VATS group (10.3%),with statistically significant difference(P<0.05).And there was no difference in NRS pain score between two groups(P>0.05).In RATS group the hospitalization cost was higher than VATS group (P<0.05).There was no statistically difference in 1-year and 2-year survival rate between two groups (P>0.05).Conclusion:Robot-assisted segmentectomy for early stage NSCLC is safe and feasible,comparing with VATS,less air leak,so it’s worth popularizing and applying.

【基金】 西安交通大学第一附属医院科研发展基金(编号:2020ZYTS-21)
  • 【文献出处】 现代肿瘤医学 ,Journal of Modern Oncology , 编辑部邮箱 ,2024年09期
  • 【分类号】R734.2
  • 【下载频次】63
节点文献中: 

本文链接的文献网络图示:

本文的引文网络